MULTI-TYROSINE KINASE INHIBITOR-ASSOCIATED APLASTIC ANEMIA AND A BRIEF LITERATURE REVIEW
Objective: Chronic myeloid leukemia (CML) is a malignancy classified under the group of chronic myeloproliferative neoplasms. It is characterized by uncontrolled leukocytosis, bleeding, thrombosis, recurrent infections, and hepatosplenomegaly. With the introduction of imatinib in 2001, followed by t...
        Saved in:
      
    
          | Main Authors: | Veysel Erol, Zeki Guzel, Mustafa Gokoglu | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Elsevier
    
        2024-12-01 | 
| Series: | Hematology, Transfusion and Cell Therapy | 
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924028785 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    TYROSINE KINASE INHIBITORS AND INTERFERON        
                          
 by: Maria Dimou, et al.
 Published: (2014-01-01)
- 
                
                    TYROSINE KINASE INHIBITORS AND PREGNANCY        
                          
 by: Elisabetta Abruzzese, et al.
 Published: (2014-04-01)
- 
                
                    Receptor Tyrosine Kinases and Inhibitors in Lung Cancer        
                          
 by: Evan Pisick, et al.
 Published: (2004-01-01)
- 
                
                    APLASTIC ANEMIA AND VIRAL HEPATITIS        
                          
 by: Laura Cudillo
 Published: (2009-11-01)
- 
                
                    APLASTIC ANEMIA  AND VIRAL HEPATITIS        
                          
 by: Laura Cudillo
 Published: (2009-11-01)
 
       